Clinical trials represent the systematic evaluation of medical treatments through human participation, establishing the foundation for modern medicine's evidence-based practices. These rigorous studies emerged formally in the 20th century, transforming how new drugs and therapies receive approval before widespread use.

Historical Development

The first recorded controlled clinical trial occurred in 1747 when James Lind, a Scottish naval surgeon aboard HMS Salisbury, tested citrus fruits against scurvy in sailors. His documented experiment compared six different treatments on twelve patients, demonstrating that citrus consumption prevented the disease. This pioneering work laid groundwork for systematic medical investigation.

Modern Clinical Trial Framework

• Phase I trials (1960s-present) - Test safety and dosage in 20-100 healthy volunteers
• Phase II trials - Evaluate effectiveness in 100-500 patient participants
• Phase III trials - Confirm effectiveness and monitor side effects in 1,000-5,000 participants
• Phase IV trials - Track long-term effects after FDA approval

Key Milestone

The Declaration of Helsinki, adopted in 1964 by the World Medical Association in Finland, established ethical guidelines for clinical research. This document mandated informed consent and institutional oversight, fundamentally protecting research participants. Today, approximately 90% of new drugs entering Phase I trials never reach market approval, demonstrating the stringent standards clinical trials maintain in ensuring patient safety and treatment efficacy.

Reference:

Wikipedia reference

https://en.wikipedia.org/wiki/Clinical_Trials